Grantham Mayo Van Otterloo & Co. LLC raised its position in Haleon plc (NYSE:HLN - Free Report) by 377.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 392,409 shares of the company's stock after buying an additional 310,194 shares during the quarter. Grantham Mayo Van Otterloo & Co. LLC's holdings in Haleon were worth $3,744,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently made changes to their positions in HLN. Yoffe Investment Management LLC bought a new position in shares of Haleon in the fourth quarter worth about $163,000. Pitcairn Co. increased its position in Haleon by 10.3% during the 4th quarter. Pitcairn Co. now owns 275,848 shares of the company's stock worth $2,632,000 after purchasing an additional 25,661 shares in the last quarter. National Bank of Canada FI lifted its stake in Haleon by 195.8% in the 4th quarter. National Bank of Canada FI now owns 13,992 shares of the company's stock valued at $133,000 after purchasing an additional 9,262 shares during the last quarter. HighPoint Advisor Group LLC grew its stake in shares of Haleon by 6.2% during the fourth quarter. HighPoint Advisor Group LLC now owns 37,768 shares of the company's stock worth $372,000 after buying an additional 2,213 shares during the last quarter. Finally, Alliancebernstein L.P. grew its stake in shares of Haleon by 28.1% during the fourth quarter. Alliancebernstein L.P. now owns 51,678 shares of the company's stock worth $493,000 after buying an additional 11,341 shares during the last quarter. Institutional investors own 6.67% of the company's stock.
Haleon Trading Up 4.3 %
Shares of HLN traded up $0.42 during mid-day trading on Friday, reaching $10.05. 16,215,293 shares of the company were exchanged, compared to its average volume of 6,970,386. The business has a 50 day simple moving average of $10.04 and a two-hundred day simple moving average of $9.81. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. The stock has a market capitalization of $45.38 billion, a PE ratio of 29.54, a PEG ratio of 2.82 and a beta of 0.24. Haleon plc has a 52 week low of $8.03 and a 52 week high of $10.80.
Haleon (NYSE:HLN - Get Free Report) last released its quarterly earnings results on Thursday, February 27th. The company reported $0.05 earnings per share (EPS) for the quarter. Haleon had a net margin of 10.85% and a return on equity of 14.76%. The firm had revenue of $3.54 billion during the quarter, compared to analyst estimates of $3.38 billion. On average, analysts predict that Haleon plc will post 0.43 earnings per share for the current fiscal year.
Haleon Increases Dividend
The company also recently declared a -- dividend, which will be paid on Thursday, June 5th. Shareholders of record on Friday, April 25th will be given a dividend of $0.1166 per share. The ex-dividend date is Friday, April 25th. This represents a yield of 1.6%. This is a boost from Haleon's previous -- dividend of $0.05. Haleon's dividend payout ratio is 58.97%.
Analyst Upgrades and Downgrades
Several equities research analysts recently weighed in on HLN shares. Deutsche Bank Aktiengesellschaft reissued a "hold" rating on shares of Haleon in a report on Monday, March 3rd. Sanford C. Bernstein lowered Haleon from an "outperform" rating to a "market perform" rating in a research note on Wednesday, January 8th. Hsbc Global Res cut Haleon from a "strong-buy" rating to a "hold" rating in a report on Wednesday, March 5th. Morgan Stanley lowered shares of Haleon from an "overweight" rating to an "equal weight" rating in a report on Friday, January 10th. Finally, HSBC reissued a "hold" rating on shares of Haleon in a report on Wednesday, March 5th. Six research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $10.95.
Check Out Our Latest Stock Analysis on HLN
Haleon Profile
(
Free Report)
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
Further Reading
Before you consider Haleon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Haleon wasn't on the list.
While Haleon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
